Application 062640
- Type
- ANDA
- Sponsor
- ACS DOBFAR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFTAZIDIME | CEFTAZIDIME | INJECTABLE;INJECTION | 500MG/VIAL | No | No |
| 002 | CEFTAZIDIME | CEFTAZIDIME | INJECTABLE;INJECTION | 1GM/VIAL | No | No |
| 003 | CEFTAZIDIME | CEFTAZIDIME | INJECTABLE;INJECTION | 2GM/VIAL | No | No |
| 004 | CEFTAZIDIME | CEFTAZIDIME | INJECTABLE;INJECTION | 6GM/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062640-001 | CEFTAZIDIME | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | ||
| A062640-002 | CEFTAZIDIME | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 |
| A062640-003 | CEFTAZIDIME | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 |
| A062640-004 | CEFTAZIDIME | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062640-002 | AP |
| A062640-003 | AP |
| A062640-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-001 | CEFTAZIDIME | 500MG/VIAL | INJECTABLE / INJECTION | 1985-11-20 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A062640-002 | CEFTAZIDIME | 1GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-003 | CEFTAZIDIME | 2GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1985-11-20 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-004 | CEFTAZIDIME | 6GM/VIAL | INJECTABLE / INJECTION | AP | RS | 1992-02-03 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A062640-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062640-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062640-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062640-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062640-004 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062640-004 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062640-004 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062640-004 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062640-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062640-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-003 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062640-004 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-003 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062640-004 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062640-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062640-003 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062640-004 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062640-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062640-003 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062640-004 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062640-002 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062640-003 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062640-004 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062640-002 | AP | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftazidime | CEFTAZIDIME | WG Critical Care, LLC | 22d6534c-4488-48a1-8d78-e2fb908259de | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 062640 ANDA062640 44567-237 |
| Ceftazidime | CEFTAZIDIME | Sagent Pharmaceuticals | aec64360-8452-4987-a366-a5a4f8762ab6 | 2024-01-03 | Warnings, Adverse reactions | 062640 ANDA062640 25021-129 |
| Ceftazidime | CEFTAZIDIME | WG Critical Care, LLC | bcc81df2-20e3-4738-bfcf-301da883c1d9 | 2023-09-11 | Warnings, Adverse reactions | 062640 ANDA062640 44567-236 44567-235 |
| Ceftazidime | CEFTAZIDIME | Sagent Pharmaceuticals | 112c5457-8d71-49f5-b531-9761d7d38c93 | 2020-10-05 | Warnings, Adverse reactions | 062640 ANDA062640 25021-127 25021-128 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-3177 | Ceftazidime | Ceftazidime | Sandoz Inc | ANDA | Current |
| 0781-3178 | Ceftazidime | Ceftazidime | Sandoz Inc | ANDA | Current |
| 0781-3179 | Ceftazidime | Ceftazidime | Sandoz Inc | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-127 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-128 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 25021-129 | Ceftazidime | ceftazidime | Sagent Pharmaceuticals | ANDA | Current |
| 44567-235 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-235 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-235 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-235 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-235 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-236 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-236 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-236 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-236 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-236 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-237 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-237 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-237 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-237 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |
| 44567-237 | Ceftazidime | Ceftazidime | WG Critical Care, LLC | ANDA | Current |